Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Corcept Therapeutics Inc (NASDAQ: CORT) closed the day trading at $61.81 down -2.72% from the previous closing price of $63.54. In other words, the price has decreased by -$2.72 from its previous closing price. On the day, 1.3 million shares were traded.
Ratios:
For a better understanding of CORT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.41. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 10 ’25 when Swisher Daniel N JR sold 2,200 shares for $68.08 per share. The transaction valued at 149,776 led to the insider holds 0 shares of the business.
Swisher Daniel N JR bought 2,200 shares of CORT for $149,776 on Feb 10 ’25. On Feb 03 ’25, another insider, Maduck Sean, who serves as the insider of the company, sold 20,000 shares for $66.92 each. As a result, the insider received 1,338,400 and left with 85,318 shares of the company.
Valuation Measures:
As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 49.16, and their Forward P/E ratio for the next fiscal year is 29.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.30 while its Price-to-Book (P/B) ratio in mrq is 10.13.
Stock Price History:
Over the past 52 weeks, CORT has reached a high of $75.00, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is 4.18%, while the 200-Day Moving Average is calculated to be 39.00%.
Shares Statistics:
A total of 104.70M shares are outstanding, with a floating share count of 92.45M. Insiders hold about 11.76% of the company’s shares, while institutions hold 80.82% stake in the company.
